Senior insider sale
Chief Medical Officer at MONTE ROSA THERAPEUTICS, INC. — senior position signals high conviction
$1.15M
53.25K shares
What this filing means
JANKU FILIP plans to sell 53.25K shares of MONTE ROSA THERAPEUTICS, INC. valued at approximately $1.15M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 6/30/2026ACC: 0001950047-26-006665
Officer· Chief Medical Officer
Since Jun 2021
53.25K
Shares to sell
$1.15M
Approx. market value
5.41K
Acquired (3 months)
1
Planned
3 completed
Securities Acquired — Last 3 Months1
Exercise of Stock Options
Cash
6/30/2026
5.41KTotal acquired5.41K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
6/30/2026 | Exercise of Stock Options Cash | 5.41K | — |
| Total | 5.41K | ||
Planned & Completed Dispositions4
Completed
—Completed
Units to sell
6K
Market value
$137.7K
6/29/2026
—Completed
Units to sell
30K
Market value
$642.7K
6/24/2026
—Completed
Units to sell
11.85K
Market value
$239.5K
6/23/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
5.41K
Market value
$129.2K
6/30/2026
Total
Units
53.25K
Value
$1.15M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
6/29/2026 | 6K | $137.7K | — | Completed |
6/24/2026 | 30K | $642.7K | — | Completed |
6/23/2026 | 11.85K | $239.5K | — | Completed |
| Planned — Approximate Date | ||||
6/30/2026 | 5.41K | $129.2K | NASDAQ | Planned |
| Total | 53.25K | $1.15M | ||